ITGB4 also promotes breast cancer cell resistance to tamoxifen-induced apoptosis by activating the PI3K/AKT signaling pathway and promotes breast cancer cell resistance to anoikis by activating RAC1 (Kim et al., 2012). This evidence concerns the gene RAC1 and breast carcinoma.